103 related articles for article (PubMed ID: 6150246)
1. Review of mortality results in randomised trials in early breast cancer.
Lancet; 1984 Nov; 2(8413):1205. PubMed ID: 6150246
[No Abstract] [Full Text] [Related]
2. Hormono-chemotherapy versus hormonotherapy followed by chemotherapy in the treatment of disseminated breast cancer.
Cavalli F; Alberto P; Jungi F; Brunner K; Martz G
Eur J Cancer (1965); 1980; Suppl 1():125-9. PubMed ID: 7032922
[No Abstract] [Full Text] [Related]
3. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801
[TBL] [Abstract][Full Text] [Related]
4. Randomized clinical trials in breast cancer: a tabular summary. Part 1: Primary breast cancer.
Conrad B; Kieser R
Arch Geschwulstforsch; 1986; 56(3):211-36. PubMed ID: 3524501
[TBL] [Abstract][Full Text] [Related]
5. [Adjuvant chemo-hormonal therapy of breast cancer. New results on mortality].
Kaufmann M; Kubli F; Caffier H; Jonat W; Maass H
Dtsch Med Wochenschr; 1985 Jun; 110(25):1009-10. PubMed ID: 3839181
[No Abstract] [Full Text] [Related]
6. Alternating cyclical hormonal-cytotoxic combination chemotherapy in postmenopausal patients with breast cancer. An EORTC trial.
Heuson JC; Sylvester R; Engelsman E
Eur J Cancer (1965); 1980; Suppl 1():113-7. PubMed ID: 7032920
[No Abstract] [Full Text] [Related]
7. Tamoxifen versus tamoxifen + mitoxantrone treatment in metastatic breast cancer.
Kars A; Baltali E; Tekuzman G; Firat D; Alakavuklar M
J Chemother; 1989 Jul; 1(4 Suppl):1196-7. PubMed ID: 16312831
[No Abstract] [Full Text] [Related]
8. Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?
Tang SC
Cancer Invest; 2008 Jun; 26(5):481-90. PubMed ID: 18568770
[TBL] [Abstract][Full Text] [Related]
9. [Current trends in the treatment of primary breast cancer].
Letiagin VP
Vopr Onkol; 1998; 44(5):632-5. PubMed ID: 9884732
[No Abstract] [Full Text] [Related]
10. Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis.
Cole BF; Gelber RD; Gelber S; Coates AS; Goldhirsch A
Lancet; 2001 Jul; 358(9278):277-86. PubMed ID: 11498214
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.
Gnant M; Mlineritsch B; Stoeger H; Luschin-Ebengreuth G; Heck D; Menzel C; Jakesz R; Seifert M; Hubalek M; Pristauz G; Bauernhofer T; Eidtmann H; Eiermann W; Steger G; Kwasny W; Dubsky P; Hochreiner G; Forsthuber EP; Fesl C; Greil R;
Lancet Oncol; 2011 Jul; 12(7):631-41. PubMed ID: 21641868
[TBL] [Abstract][Full Text] [Related]
12. Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Analysis at six years by Nolvadex Adjuvant Trial Organisation.
Lancet; 1985 Apr; 1(8433):836-40. PubMed ID: 2858709
[TBL] [Abstract][Full Text] [Related]
13. Testing "the soft option": trials of adjuvant endocrine therapy for the primary treatment of breast cancer.
Ebbs SR; Baum M
Isr J Med Sci; 1988; 24(9-10):552-6. PubMed ID: 3060445
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant tamoxifen in the management of operable breast cancer: the Scottish Trial. Report from the Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC), Edinburgh.
Lancet; 1987 Jul; 2(8552):171-5. PubMed ID: 2885637
[TBL] [Abstract][Full Text] [Related]
15. [Adjuvant therapy in breast carcinoma. A specific immunologic preliminary contribution].
Fazio M; Calabrese F; Giacomasso S; Mastromatteo V; Negri L
Minerva Chir; 1988 Sep; 43(18 Suppl):59-62. PubMed ID: 3226597
[No Abstract] [Full Text] [Related]
16. [Treatment of drug-resistant metastasizing cancer of the breast with an antiestrogen].
Frederiksen PL; Engelholm A; Mouridsen HT
Ugeskr Laeger; 1978 Oct; 140(43):2639-41. PubMed ID: 360540
[No Abstract] [Full Text] [Related]
17. Adjuvant systemic treatment for breast cancer meta-analysed.
Lancet; 1989 Jan; 1(8629):80-1. PubMed ID: 2562885
[No Abstract] [Full Text] [Related]
18. Therapeutic effect of tamoxifen versus combined tamoxifen and diethylstilboestrol in advanced breast cancer in postmenopausal women.
Mouridsen HT; Salimtschik M; Dombernowsky P; Gelshoj K; Palshof T; Rorth M; Daehnfeldt JL; Rose C
Eur J Cancer (1965); 1980; Suppl 1():107-10. PubMed ID: 7032918
[No Abstract] [Full Text] [Related]
19. [Adjuvant therapy in breast neoplasms].
Senn HJ
Aktuelle Probl Chir Orthop; 1982; 22():52-60. PubMed ID: 6121514
[No Abstract] [Full Text] [Related]
20. Adjuvant therapy with tamoxifen in operable breast cancer. 10 year results of the Naples (GUN) study.
Bianco AR; De Placido S; Gallo C; Pagliarulo C; Marinelli A; Petrella G; D'Istria M; Delrio G
Lancet; 1988 Nov; 2(8620):1095-9. PubMed ID: 2903322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
